Company / Net Debt per Share
Emergent BioSolutions Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$7.38
FY2025
5-year range
$5.33 / $15.03
FY2021-FY2025
Trend
-33.3%
vs FY2024
Sector context
#24 of 82
Health Care
What the data says
At $7.38, Emergent BioSolutions Inc.'s net debt per share ranks #59 of 82 in the Health Care sector. Net Debt per Share has declined for 3 consecutive years, from $15.03 in FY2022 to $7.38 in FY2025.
Based on SEC 10-K filings.
7.38 in FY2025 with a 5-year CAGR of +7.6%.
Improved from $14.50 to $7.38 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -21.1%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
#59 of 82 in Health CareTop 71% of 82This company $7.38 Sector average $13.70
▼
-46.1% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s net debt per share has declined for 3 consecutive years.
- In FY2025, net debt per share decreased 33.3% year-over-year.
- Ranks #24 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.38 | -33.3% |
| FY2024 | $11.06 | -23.7% |
| FY2023 | $14.50 | -3.6% |
| FY2022 | $15.03 | +182.0% |
| FY2021 | $5.33 | +4.3% |
| FY2020 | $5.11 | -59.6% |
| FY2019 | $12.66 | -0.8% |
| FY2018 | $12.76 | +414.4% |
| FY2017 | -$4.06 | -583.4% |
| FY2016 | -$0.59 | +66.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026